“The MOSAICA technology is a next-generation biopsy tool that will enable scientists and clinicians to simultaneously profile many biomarkers in cells and tissues. The ability to characterize the cellular composition, function and interaction within complex tumors will inform personalized disease diagnosis and therapeutic treatment,” says Weian Zhao, Ph.D., UCI professor of pharmaceutical sciences and study co-corresponding author.